The Conygar Investment Company PLC has secured a planning approval for the next phase of The Island Quarter development in Nottingham. The application comprises a 23,123m² bioscience building, which includes both laboratory and office space. The permission is subject to the documentation of the section 106 agreement.
Robert Ware, Chief Executive of Conygar, commented: "We are delighted that the next phase of development has been approved. Nottingham is already home to a large number of exciting businesses in the bioscience space and this scheme will be an excellent addition to the mixed-use development we are creating at The Island Quarter".
